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Cornamonas acidovorans (formerly Pseudomonas acidovorans) 
is a ubiquitous Gram-negative rod commonly found in 
soil and water. Although generally considered to be 
non-pathogenic, C. acidovorans has been associated with 
serious infections. In a comprehensive search of the 
scientific literature from the last 10 years (MEDLINE) 
we found no published case reports of urinary tract 
infections (UTIs) due to C. acidouorans. This paper 
appears to be the first report of the isolation of this 
microorganism from a UTI  and its identification as a 
pathogen. 
A 61-year-old male with hemiplegia was hospital- 
ized to allow the study of a vertiginous syndrome. 
Six days later, the patient developed oliguria and a 
vesical catheter was put in place to control diuresis. The 
patient’s clinical condition worsened, and he developed 
urethral discomfort and pyuria. The urine obtained at 
this time was strongly foul-smelling; the pH was 8 
and the microscopic analysis showed pyuria (>50 
leukocytes per high-power field), microhematuria and 
bacteriuria. The nitrite test was positive. Gram staining 
showed Gram-negative rods. Urine culture was done in 
CLED agar and yielded pure growth of Gram-negative, 
oxidase-positive rods (> 100 000 CFU/mL urine). The 
biochemical characteristics of the isolate were studied 
with the API 20 NE system (bioMerieux, Marcy 
l’Etoile, France). The strain was identified as C. acido- 
uorans by the API 20 NE identification system; its 
analytical profile was 1004466. 
Antimicrobial susceptibility measured by the disk 
agar diffusion method showed that our strain was 
susceptible to ticarcillin, cefotaxime, aztreonam, imi- 
penem, norfloxacin, ciprofloxacin and co-trimoxazole 
and resistant to ampicillim, tobramicin, amikacin and 
fosfomicin. The patient was treated with a 2-week 
course of norfloxacin (400 mg orally twice daily). A 
prompt therapeutic response was acoinpanied by 
resolution of the dysuria and frequency. Further urine 
analysis showed four to seven leukocytes per high- 
power field, and cultures were negative. 
The genus Cornamonas was created in 1985 by 
De Vos et a1 [l] and initially included only one species, 
C. terr<cena. However, two additional species were 
added in 1987 by Tamakoa et a1 [2]: C. acidovorans 
(previously Pseudomonas acidouorans) and C. testosteroni 
(previously Pseudomonas testorteroni). A limited number 
of infections caused by C. acidovorans have been 
sporadically reported, including endocarditis [3] ,  ocular 
infections [4,5], acute suppurative otitis [6] and 
bacteremia [7-91. This microorganism has also been 
recovered from inhalation equipment and from clinical 
specimens, but it was considered to be a contaminant 
in these cases [lo]. 
The susceptibility pattern of our isolate shows a 
similar resistance phenotype to those strains reported 
previously. Although C. acidovorans is probably of low 
pathogenicity, its presence in any type of specimen 
would certainly warrant susceptibility testing. 
Because of the ubiquitous character of this micro- 
organism, establishing its pathogenicity may be difficult. 
Our  patient presented with a clear case of UTI due 
to a Gram-negative rod. C. acidouorans was the only 
organism isolated from the urine of this patient and, 
since the symptoms resolved after the organism was 
eliminated by antibiotic treatment, we believe that this 
organism was the etiologic agent of the infection. 
Further studies should clarifj the precise contribution 
of C. acidovorans to the pathogenicity of infection, 
especially in irnmunocompromised patients. 
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High-level cephalosporinase-producing Enterobacter 
cloacae meningitis in a newborn 
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Enterobacter cloacae is an uncommon cause of meningitis. 
The organism is known to mutate to produce large 
amounts of cephalosporinase able to hydrolyze third- 
generation cephalosporins [l], which are often thought 
to be responsible for the selection of such resistant 
mutants. 
A newborn female, born at full term by vaginal 
delivery, was admitted to the neonatal intensive care 
unit with a lumbar meningomyelocele. Apgar scores 
were 10 and 10 at 1 and 5 min, respectively. Physical 
examination revealed an active neonate with only 
bladder dysfunction. No signs of neonatal infection 
were noted, and the serum C-reactive protein (CRP) 
level was less than 10 mg/L. 
Surgical closure of the meningomyelocele was 
performed 2 days later (day 3). Preoperative smears of 
the meningomyelocele were obtained for bacteriologic 
culture, and scanty Staphylococcus haemolyticus, Escherichia 
coli and Enterobacter cloacae were isolated. Postopera- 
tively, the patient became subfebrile. The peripheral 
white blood cell count was 10760/mm3, including 
63% polymorphonuclear leukocytes and 21% lympho- 
cytes, and serum CRP increased to 37 mg/L on day 4 
and then to 99 mg/L on day 5. The antibiotic suscepti- 
bilities of the Enterobacter cloacae is shown in Table 1. 
Therapy was initiated on day 5 with cefotaxime and 
vancomycin given intravenously (50 mg/kg 6-hourly 
and 10 mg/kg 12-hourly, respectively). 
Eight days after surgery, the patient had a rectal 
temperature between 38 and 39OC, and developed 
vomiting, a stiff neck and convulsions. She developed 
severe apnea and brachycardia which required mech- 
anical ventilation. Serum CRP levels remained in- 
creased at 196 mg/L on day 11, when we replaced 
vancomycin with fosfomycin (100 mg/kg 12-hourly). 
On day 12, cerebrospinal fluid cultures yielded Entero- 
bacter cloacae. Cerebrospinal fluid (CSF) contained 1094 
nucleated cells/mm3 (86% neutrophils, 14% monocytes). 
This isolate was susceptible in vitro to carbapenems, 
cefepime, ciprofloxacin, fosfomycin and aminoglyco- 
sides but was shown to produce high-level, derepressed 
cephalosporinase. In order to verify that the two 
Enterobacter cloacae isolates were clondy related, pulsed- 
field gel electrophoresis was performed on intact DNA 
preparations, as previously described for S. aureus [2], 
except that lysostaphin was not added (Figure 1). The 
results indicated that the two isolates were related. The 
second strain was therefore considered to be a resistant 
mutant of the previous strain. This prompted us to 
replace cefotaxime with imipenem (50 mg/kg three 
times daily). However, the infant developed ventricular 
dilatation, and on day 15 a ventricular external shunt 
was put in place. At this time, the CSF white cell count 
was 230/mm3, with 98% polymorphonuclear leuko- 
cytes, the protein content was 439 mg/mL and no 
glucose was found in the CSE Enterobacter cloacae was 
isolated from further CSF cultures. 
On day 17, because of poor CSF concentrations of 
imipenem (day 17, 1 mg/L; day 18, 0.1 mg/L) and 
according to previously published data [3], cefepime 
(37.5 mg/kg every 6 h) was substituted and on day 19 
amikacin (7.5 mg/kg every 12 h) was added. The in 
vitro bactericidal activity of this combination was 
Table 1 Antibiotic susceptibhty of the two strains isolated from cerebrospinal fluid before and after treatment with cefotaxime 
Methods Antibiotics Enterobacter cloacae 1 Enterobacter cloacae 2 
Amikacin 4/16 4/16 
MIC/MBC by macro Cefotaxime 1/4 32/256 
broth dilutions (mg/L) Cefepime 4/16 4/16 
Imipenem 2/32 4/32 
